EXOSC10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.385190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.833730E-02
Normal-vs-Stage2
1.743990E-01
Normal-vs-Stage3
3.235800E-02
Normal-vs-Stage4
9.525200E-01
Stage1-vs-Stage2
3.093400E-01
Stage1-vs-Stage3
2.309600E-01
Stage1-vs-Stage4
2.284200E-02
Stage2-vs-Stage3
5.214100E-02
Stage2-vs-Stage4
1.023820E-01
Stage3-vs-Stage4
2.767900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.542800E-01
Normal-vs-AfricanAmerican
1.382370E-01
Normal-vs-Asian
1.847420E-01
Caucasian-vs-AfricanAmerican
8.962800E-01
Caucasian-vs-Asian
7.787400E-01
AfricanAmerican-vs-Asian
9.461400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.646300E-02
Normal-vs-Female
2.348000E-01
Male-vs-Female
4.205000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.423600E-02
Normal-vs-Age(41-60Yrs)
3.379000E-01
Normal-vs-Age(61-80Yrs)
9.280200E-02
Normal-vs-Age(81-100Yrs)
5.427900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.677200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.664200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.503400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.260000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.682000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.946380E-01
Normal-vs-Daily Drinker
1.680020E-01
Normal-vs-Weekly Drinker
1.823850E-01
Normal-vs-Occasional Drinker
3.267800E-01
Normal-vs-Social Drinker
2.503700E-02
Non Drinker-vs-Daily Drinker
2.585600E-01
Non Drinker-vs-Weekly Drinker
6.775400E-01
Non Drinker-vs-Occasional Drinker
5.979600E-02
Non Drinker-vs-Social Drinker
4.696400E-01
Daily Drinker-vs-Weekly Drinker
5.721600E-01
Daily Drinker-vs-Occasional Drinker
3.403200E-01
Daily Drinker-vs-Social Drinker
5.635200E-01
Weekly Drinker-vs-Occasional Drinker
1.939250E-01
Weekly Drinker-vs-Social Drinker
9.062400E-01
Occasional Drinker-vs-Social Drinker
1.076160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.332800E-01
Normal-vs-Grade 2
9.597400E-01
Normal-vs-Grade 3
9.274400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.340490E-02
Grade 1-vs-Grade 3
2.079600E-02
Grade 1-vs-Grade 4
9.332800E-01
Grade 2-vs-Grade 3
4.666200E-01
Grade 2-vs-Grade 4
9.597400E-01
Grade 3-vs-Grade 4
9.274400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.741900E-02
Normal-vs-NonDiabetic
1.579420E-01
Diabetic-vs-NonDiabetic
4.147200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.771800E-02
Normal-vs-NoPancreatitis
1.482640E-01
Pancreatitis-vs-NoPancreatitis
8.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.646200E-02
Normal-vs-N1
1.865370E-01
N0-vs-N1
3.515800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.662400E-01
Normal-vs-TP53-NonMutant
7.013800E-02
TP53-Mutant-vs-TP53-NonMutant
1.608810E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
